ReleaseWire

Global Markets Direct's, 'Allergic Conjunctivitis - Pipeline Review, H2 2014', provides an overview of the Allergic Conjunctivitis's therapeutic pipeline.

Global Markets Direct's, 'Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H2 2014', provides an overview of the Peripheral Neuropathy (Sensory Neuropathy)'s therapeutic pipeline.

Global Markets Direct's, 'Hawaii Biotech, Inc. - Product Pipeline Review - 2014', provides an overview of the Hawaii Biotech, Inc.'s pharmaceutical research and development focus.

Tourette Syndrome Global Clinical Trials Review, H2, 2014

GBI Research, the leading business intelligence provider, has released its latest research, "Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM", which provides in-depth analysis of the Glioblastoma Multiforme (GBM) therapeutics market within the Asia-Pacific (APAC) region, covering Australia, China, India and Japan. The report provides estimates of market size for 2013, along with market forecasts until 2020. It also covers disease epidemiology, treatment algorithms, treatment patterns, and in-depth analysis of the marketed and pipeline products.

Global Markets Direct's, 'ManRos Therapeutics - Product Pipeline Review - 2014', provides an overview of the ManRos Therapeutics's pharmaceutical research and development focus.

Vascular Dementias Global Clinical Trials Review, H2, 2014

Global Markets Direct's, 'NeoPharm Co., Ltd. - Product Pipeline Review - 2014', provides an overview of the Neopharm Ltd.'s pharmaceutical research and development focus.

Global Markets Direct's, 'Intezyne, Inc - Product Pipeline Review - 2014', provides an overview of the Intezyne, Inc's pharmaceutical research and development focus.

Relmada Therapeutics, Inc., a clinical-stage company developing novel therapies for the treatment of chronic pain, announced today that it has entered into an agreement with Memorial Sloan Kettering Cancer Center (MSKCC) in a series of animal studies for levorphanol, the active ingredient of LevoCap ER, a new tamper-resistant, extended release form of levorphanol. Gavril Pasternak, MD, PhD, of MSKCC is the lead investigator for these studies.

TapImmune Inc. is extremely pleased to report that analysis of the interim data from the first 13 patients in a Phase I clinical trial show that each of the patients treated have raised specific T-cell immune responses against a set of 5 naturally processed folate receptor alpha Class II antigenic epitopes. All five of the constituent peptides were found to be immunogenic and all patients developed immune responses to at least one and in most cases more than one of the vaccine peptides.

Global Markets Direct's, 'Diabetic Neuropathy - Pipeline Review, H2 2014', provides an overview of the Diabetic Neuropathy's therapeutic pipeline.

Global Markets Direct's, 'Typhoid Fever - Pipeline Review, H2 2014', provides an overview of the Typhoid Fever's therapeutic pipeline.

Global Markets Direct's, 'Braasch Biotech LLC - Product Pipeline Review - 2014', provides an overview of the Braasch Biotech LLC's pharmaceutical research and development focus.

Global Markets Direct's, 'Chemotherapy Induced Anemia - Pipeline Review, H2 2014', provides an overview of the Chemotherapy Induced Anemia's therapeutic pipeline.

Global Markets Direct's, 'Aprea AB - Product Pipeline Review - 2014', provides an overview of the Aprea AB's pharmaceutical research and development focus.

Global Markets Direct's, 'Lupus Nephritis - Pipeline Review, H2 2014', provides an overview of the Lupus Nephritis's therapeutic pipeline.

CoLucid Pharmaceuticals, Inc. - Product Pipeline Review - 2014

Global Markets Direct's, 'Neuroblastoma - Pipeline Review, H2 2014', provides an overview of the Neuroblastoma's therapeutic pipeline.

Critical Limb Ischemia Global Clinical Trials Review, H2, 2014

Reata Pharmaceuticals, Inc. - Product Pipeline Review - 2014

Metastatic Colorectal Cancer - Pipeline Review, H2 2014

Northern Antibiotics Oy - Product Pipeline Review - 2014

Faron Pharmaceuticals Oy - Product Pipeline Review - 2014

Global Markets Direct's, 'Amplyx Pharmaceuticals, Inc. - Product Pipeline Review - 2014', provides an overview of the Amplyx Pharmaceuticals, Inc.'s pharmaceutical research and development focus.